Transparency data

Aggregate net sales and payment information: 19 August 2020

Published 23 October 2020

© Crown copyright 2020

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: [email protected].

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at /government/publications/voluntary-scheme-aggregate-net-sales-and-payment-information-august-2020/aggregate-net-sales-and-payment-information-19-august-2020

Table 1: unaudited sales reports � measured sales

Year 2019 voluntary scheme Statutory scheme Parallel imports Total
2018 Q1 £2,150³¾ £393³¾ £139³¾ £2,683³¾
2018 Q2 £2,191³¾ £414³¾ £146³¾ £2,751³¾
2018 Q3 £2,237³¾ £422³¾ £150³¾ £2,809³¾
2018 Q4 £2,285³¾ £424³¾ £160³¾ £2,870³¾
2018 £8,868³¾ £1,651³¾ £595³¾ £11,114³¾
2019 Q1 £2,193³¾ £413³¾ £147³¾ £2,752³¾
2019 Q2 £2,174³¾ £430³¾ £141³¾ £2,745³¾
2019 Q3 £2,302³¾ £420³¾ £133³¾ £2,855³¾
2019 Q4 £2,394³¾ £425³¾ £144³¾ £2,963³¾
2019 £9,052³¾ £1,684³¾ £566³¾ £11,302³¾
2020 Q1 £2,747³¾ £101³¾ £158³¾ £3,005³¾
2020 Q2 £2,407³¾ £96³¾ £142³¾ £2,644³¾

Table 1 notes

  1. Table 1 sets out aggregate information about measured sales subject to the affordability mechanism. It includes information received on parallel imports and information from audited annual sales reports and unaudited quarterly sales reports provided by members of the 2019 voluntary scheme and the statutory scheme.
  2. The baseline for measured sales in respect of the statutory scheme and parallel imports has been calculated in accordance with annex 4, paragraph 1 of the 2019 voluntary scheme.
  3. ‘Measured sales� is defined in the glossary of the 2019 voluntary scheme for branded medicines pricing and access as ‘sales of scheme products by scheme members, statutory scheme sales and parallel import sales, but excluding exemptions from measured sales�.
  4. Figures for the 2019 voluntary scheme reflect any audited sales reports received. Annual totals from 2019 onwards for the statutory scheme reflect any audited sales reports received.
  5. Measured sales in any particular period reflects all relevant scheme members in either the 2019 voluntary scheme or statutory scheme during that period. For example, several companies moved from the statutory scheme to the voluntary scheme at the start of 2020. Those companies� measured sales will appear under the statutory scheme in 2019 and the voluntary scheme in 2020.
  6. All figures are in millions (m).

Table 2: 2019 voluntary scheme sales reports � eligible sales and resulting total scheme payments

Period Aggregate eligible sales Resulting aggregate scheme payments
2019 Q1 £2,062³¾ £198³¾
2019 Q2 £2,111³¾ £203³¾
2019 Q3 £2,256³¾ £216³¾
2019 Q4 £2,339³¾ £225³¾
2019 £8,757³¾ £841³¾
2020 Q1 £2,540³¾ £150³¾
2020 Q2 £2,285³¾ £135³¾

Table 2 notes

  1. Table 2, which is derived from unaudited quarterly sales reports and any audited annual sales reports received from members of the 2019 voluntary scheme, sets out aggregate information showing eligible sales covered by the scheme payment and the resulting scheme payments.
  2. ‘Eligible sales� is defined in the glossary of the 2019 voluntary scheme as ‘sales of scheme products but excluding exemptions from eligible sales�. The percentage payment applies to these sales. Eligible sales excludes certain types of sales, including the first £5 million of sales by a medium-sized company and new active substance (NAS) sales. Both of these sales categories are, however, included in measured sales and, therefore, the calculation of the overall sum to be repaid across all scheme members.
  3. All figures are in millions (m).

Table 3: statutory scheme sales reports � net sales covered by the statutory scheme payment and resulting payments

Statutory scheme payment and resulting payments Jan to Mar 2019 Apr to Jun 2019 Jul to Sep 2019 Oct to Dec 2019 Jan to Mar 2020 Apr to Jun 2020
Aggregate net sales covered by the applicable annual statutory scheme payment (a) £140³¾ £137³¾ £171³¾ £188³¾ £6³¾ £8³¾
Resulting aggregate statutory scheme payment (b) £14³¾ £14³¾ £17³¾ £19³¾ £1³¾ <£1³¾
Net sales of extant frameworks and public contracts subject to 7.8% payment (c) £53 m £85³¾ £81³¾ £76³¾ £4³¾ £4³¾
Resulting statutory scheme 7.8% payment (d) £4³¾ £7³¾ £6³¾ £6³¾ <£1³¾ <£1³¾
Total resulting statutory scheme payment (b + d) £18³¾ £20³¾ £23³¾ £24³¾ £1³¾ £1³¾

Table 3 notes

  1. Table 3 is derived from unaudited statutory scheme sales reports. It sets out aggregate unaudited quarterly information showing net sales covered by the statutory scheme payment and the resulting payments.
  2. All figures are in millions (m).

General notes

  1. The information in all tables is that held on the Department of Health and Social Care’s database on 19 August 2020.
  2. Totals may not sum due to rounding.
  3. All tables are subject to future correction such as where audited data replaces best available data and will be updated at each quarterly publication point to reflect the latest available information. The audit and reconciliation arrangements are set out in paragraphs 4.26 to 4.31 of the 2019 voluntary scheme. The statutory scheme audit requirements are set out at paragraph 23 of the regulations.
Back to top